Increased CD8+ and reduced CD4+CD25+ regulatory T cells (Tregs) were consistently detected in blood and tumor tissues from mice treated with BMDCTEX-N1ND compared with other groups (Fig. 2b, c and Supplementary Fig. 2a, b). This evidence concerns the gene CD4 and neoplasm.